Skip to main content

Table 1 Overview of the WHO 2013 strategic plan for schistosomiasis [85]

From: Evaluating the variation in the projected benefit of community-wide mass treatment for schistosomiasis: Implications for future economic evaluations

Goals

1. To control morbidity due to schistosomiasis by 2020 (defined as 100% geographical coverage, 75% national coverage and < 5% prevalence of heavy-intensity infections across all sentinel sites).

2. To eliminate schistosomiasis as a public-health problem by 2025 (defined as a prevalence of heavy-intensity infections < 1% in all sentinel sites).

3. To interrupt transmission of schistosomiasis in the Region of the Americas, the Eastern Mediterranean Region, the European Region, the South-East Asia Region and the Western Pacific Region, and in selected countries of the African Region by 2025 (defined as reduction to zero incidence of infection).

Objectives

1. To scale-up control and elimination activities in all endemic countries

2. To ensure an adequate supply of praziquantel and resources to meet the demand